Seeing as the company is heavily invested in moving into the hernia device space, its unlikely you will get a critical response or definitive answer. I agree with your sentiment, its going to take some convincing or a very slow uptake to get sales penetration, no different to how BTM has progressed since 510k FDA approval.
Good luck with your correspondence to the company.
Ann: BTM CE mark approval, page-158
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.73 |
Change
0.050(1.87%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.75 | $2.66 | $1.522M | 561.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 17838 | $2.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.74 | 11621 | 13 |
View Market Depth
| Last trade - 11.19am 01/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |